Find the best CNRS technologies to boost your innovative project.
06.11.2018
Materials – Coating 07293-01
06.11.2018
Materials – Coating 10581-01
06.11.2018
Chemistry / Environment 08758-01
06.11.2018
11127-01
06.11.2018
Environment and Energy 11107-01
19.10.2018
Medical Diagnostic 08504-01
We can guide you through the whole technology transfer process.
Thanks to our expertise, our network and our know-how of the innovation ecosystem, we support you throughout your project.
01839-01
French patent application FR2940973 filed on January 15th, 2009, entitled «Identification d’une nouvelle toxine antagoniste de canaux calciques de type-T à visée analgésique»
Emmanuel BOURINET
Pierre ESCOUBAS
Joël NARGEOT
Fabrice MARGER
Michel LAZDUNSKI
Exclusive or non-exclusive licenses
Institut de Génomique Fonctionnelle a CNRS–INSERM and University de Montpellier laboratory (UMR 5203), in Montpellier, France.
Transmission of the pain signal by the nervous system involves neuronal receptors which convert the painful stimulus into an electrical signal. The nociceptive neurons, which react specifically to pain stimuli, possess a unique repertory of ion channels that represent ideal targets for new analgesic drug development. Among them, T-type Calcium channels, and in particular CaV3.2, have been shown to be specifically implicated in nociception.
The inventors have identified PspTx3, a 28 aa-peptide derived from the venom of a spider Theraphosidae, that efficiently inhibits CaV3.2. Besides, PspTx3 revealed to also efficiently inhibit NaV1.7, a sodium channel implicated in pain conduction and a very interesting target for pain treatment. Using a mouse model of chronic pain induced by sciatic nerve lesion, the peripheral injection of the toxin (subcutaneous injection in the leg) showed a much more potent effect on nociception compared to morphine. No cardiac toxicity could be detected.
Drug development for use in pain treatment.
For further information, please contact us (Ref 01839-01)
31.03.2015
Health / Therapeutic, Medical Diagnostic 06081-01
10.03.2014
Health / Therapeutic, Other Technologies 00017-04
03.03.2014
Health / Therapeutic 03946-01
06.11.2018
Materials – Coating 07293-01
06.11.2018
Materials – Coating 10581-01
06.11.2018
Chemistry / Environment 08758-01
06.11.2018
11127-01
06.11.2018
Environment and Energy 11107-01
19.10.2018
Medical Diagnostic 08504-01